Instalab
logoInstalab

BMD Z-Score

See whether your spine bones are keeping pace with people your age, before a fracture forces the conversation.
4.9 (2,343 reviews)
Physician-reviewed results
How it works
Order from Instalab
No prescription or your own doctor's order needed
Get blood drawn
At home
Get results
Explained with clear next steps, no medical jargon

Should you take a BMD Z-Score test?

This test is most useful if any of these apply to you.

Worried About Bone Loss Running In Your Family
If a parent had a hip or vertebral fracture, your bone trajectory may already be diverging from your peers and worth measuring now.
Taking Steroids For A Chronic Condition
Long-term prednisone or similar drugs erode spine bone density within weeks, and a baseline scan lets you protect what you have.
Training Hard With A Lean Frame
Endurance athletes and lean lifters often carry surprisingly low spine bone density that no other lab catches.
Healthy But Want To Stay Ahead
Knowing your baseline now means you can see whether your spine is holding steady or quietly losing ground over the next decade.

About BMD Z-Score

Bone loss is silent until something breaks. A lumbar spine BMD Z-score (bone mineral density Z-score) gives you a way to see whether your spine is tracking with people your age, or quietly falling behind, long before a fracture shows up on imaging.

The number you get from this scan is not a snapshot of your spine in isolation. It is a comparison: how your bone mineral density at the lower back stacks up against age- and sex-matched norms, expressed in standard deviations. That makes it especially useful for younger adults, athletes, and anyone with a chronic condition that can erode bone.

What This Number Actually Tells You

A lumbar spine Z-score is not a molecule or a hormone. It is a statistical comparison derived from a DXA scan (dual-energy X-ray absorptiometry, the standard bone density imaging test). A Z-score near 0 means your spine bone density sits near the average for your age and sex. A negative number means below average. A positive number means above.

This matters because spine bone density reflects the running balance between how fast your body builds new bone and how fast it breaks down old bone. That balance is shaped by hormones, nutrition, weight-bearing activity, inflammation, and a long list of chronic conditions. A Z-score gives you one summary number that captures the net result of all of those forces at the part of the skeleton most prone to vertebral fractures.

Why Spine, And Why Z-Score

The lumbar spine is rich in trabecular bone, the spongy inner tissue that turns over faster than the dense cortical bone in your hip. That higher turnover makes the spine the first place to show the effects of hormonal shifts, steroid medications, or chronic disease. It is also where vertebral compression fractures actually happen.

Z-scores compare you to your peers. T-scores, which you may have seen on a bone density report, compare you to a healthy young adult. For people under 50, for premenopausal women, and for anyone trying to catch problems early, the Z-score is the more relevant lens. A Z-score of -2.0 or lower is widely used as a threshold for bone density that is below the expected range for your age.

Conditions Linked To Low Spine Z-Scores

A low spine Z-score is not a disease on its own. It is a signal that the body's bone economy has been disrupted, often by an identifiable cause. The list of conditions associated with reduced lumbar spine Z-scores is long, and the actionable insight is that knowing the number can prompt the right workup.

Population studiedSpine Z-score pattern
Elite cyclistsAverage Z-score from around -0.3 to -1.5, with 27 to 64 percent below -1
Children on long-term steroidsHigher cumulative dose tracks with lower Z-score and more vertebral fractures
Adults with HIV not yet on treatmentAbout 1 in 10 had a Z-score at or below -2.0
Adults with sickle cell disease43 percent had a Z-score at or below -2.0; lower scores linked to worse pain
Childhood cancer survivorsPooled Z-score around -0.85 in children, -0.46 in adult survivors

What this means for you: if your Z-score is unexpectedly low, the next step is figuring out why. Chronic kidney disease, untreated celiac disease, hyperthyroidism, low testosterone or estrogen, anorexia, inflammatory bowel disease, and prolonged glucocorticoid use are all worth ruling out. A low number is the prompt, not the answer.

Vertebral Fracture Risk

Lower lumbar Z-scores consistently track with higher rates of vertebral fractures in people with secondary osteoporosis, steroid exposure, Duchenne muscular dystrophy, and other chronic conditions. The link is strongest at the most negative end of the scale, but it is not absolute. Many children and adults with confirmed vertebral fractures have Z-scores above -2.0, which means a normal-looking number does not rule out fracture if symptoms or imaging suggest one.

What this means for you: treat your Z-score as one piece of a fracture risk picture, not the verdict. Back pain that is new, height loss, or a fall with disproportionate pain still warrants imaging even if your most recent Z-score looks reassuring.

When High Numbers Are Not Good News

Most readers think of bone density as a more-is-better number. With the lumbar spine Z-score, that intuition fails at the high end. Very high Z-scores, typically above +2.5 to +4.0, are usually not a sign of unusually strong bones. They more often reflect artifacts on the scan or an underlying condition.

In a series of nearly 15,000 adults, degenerative changes in the spine, including arthritis, bone spurs, and diffuse idiopathic skeletal hyperostosis (a condition where ligaments around the spine harden and calcify), were the leading cause of elevated bone mass readings. Other causes included renal bone disease, blood cancers, and bone metastases. A small fraction reflected true high bone mass conditions, but most did not. Apparent strength on a Z-score can mask real fragility elsewhere.

This is the part to sit with: a low number and a high number can both warrant investigation. The framework that resolves the apparent contradiction is that the Z-score is a phenotype indicator, not a good-or-bad scalar. It points to which questions to ask next, and the right questions differ depending on which direction it deviates.

Reference Ranges

There is no single universally standardized reference range for lumbar spine Z-scores. Values depend on the DXA machine used, the normative database the scan is compared against, and your age, sex, and ancestry. In one analysis of children with leukemia, the same raw bone density translated into Z-scores that differed by as much as 2 full standard deviations depending on which reference database was used. Treat the categories below as orientation, not absolute cutpoints.

TierZ-score rangeWhat it suggests
Below expected for age-2.0 or lowerBone density meaningfully below age-matched peers; warrants workup for secondary causes
Within expected rangeRoughly -1.9 to +2.4Bone density consistent with what is typical for your age and sex
Elevated+2.5 or higherMay reflect spine degenerative changes, artifact, or rarer high-bone-mass conditions

What this means for you: compare your results against the same lab and the same machine over time. A change of 0.3 or more between scans on the same machine is more clinically meaningful than crossing an arbitrary tier line.

Why One Reading Is Not Enough

DXA precision is good but not perfect. The smallest detectable difference in spine bone density on a repeat scan is typically larger than people expect, meaning that small changes between scans could simply be measurement noise. One analysis found that short-term variability in spine measurements is constant across a wide range of values, and that judging change against a per-individual smallest detectable difference is more reliable than treating any percent change as real.

This makes serial tracking essential. A single Z-score tells you where you are. Two scans tell you which direction you are moving. Three or more start to reveal whether a treatment, lifestyle change, or new medication is actually shifting your bone trajectory. The line slope matters more than any single dot.

A reasonable cadence: get a baseline scan now if you have any reason to suspect low bone density or you are over 40 with risk factors. If your baseline is concerning or you start an intervention, retest in 12 to 24 months on the same machine. If your baseline is reassuring and you have no major risk factors, retest at least every 2 to 3 years. Earlier and more often if you are on chronic steroids, have a chronic disease known to affect bone, or experience a fragility fracture.

When Results Can Be Misleading

Several things can shift your Z-score without reflecting your true bone biology. Knowing them helps you interpret an unexpected number.

  • Degenerative spine changes: arthritis, bone spurs, and ligament calcification artificially raise the apparent bone density at the spine. Severe lumbar degenerative disease is the single largest contributor to falsely elevated readings.
  • Body size in children and adolescents: unadjusted Z-scores can over-diagnose low bone mass in shorter children and under-diagnose it in taller ones. Height-for-age adjustment changed the diagnosis in about 7 percent of pediatric scans in one study. Ask whether your child's report includes a size adjustment.
  • Machine and database differences: in healthy children, the percentage flagged as having low Z-scores varied several-fold between DXA centers, even when scanning the same population. Always compare scans done on the same machine when possible.
  • Vertebral fractures themselves: a compressed vertebra can paradoxically raise the bone density reading at that level because the same mineral is squeezed into a smaller area. Radiologists typically exclude such vertebrae from the calculation, but errors happen.

What To Do With An Abnormal Result

If your spine Z-score is at or below -2.0, the priority is identifying why. Companion labs worth ordering include 25-hydroxyvitamin D, calcium, phosphorus, parathyroid hormone, thyroid stimulating hormone, and, depending on context, testosterone or estradiol, celiac antibodies, and kidney function markers. An endocrinologist or a clinician with focused expertise in metabolic bone disease is the right next stop if the workup is complicated or your scan changed quickly.

If your Z-score is above +2.5, talk to your clinician about whether the elevation is explained by degenerative changes on the scan, or whether further investigation for renal bone disease, hematologic conditions, or rarer skeletal disorders is warranted. A radiologist's read of the scan images, not just the Z-score number, often clarifies the cause.

In both directions, a single abnormal scan is rarely a reason to start medication. The decision pathway runs through cause first, trajectory second, and treatment third.

What Moves This Biomarker

Evidence-backed interventions that affect your BMD Z-Score level

Increase
Zoledronate, an annual intravenous bisphosphonate
Yearly zoledronate is a standard treatment for osteoporosis that meaningfully raises spine bone density. In a 3-year randomized trial in postmenopausal women with osteoporosis, lumbar spine bone density rose about 9.6 percent on zoledronate versus about 1.4 percent on placebo, alongside improvements in bone microarchitecture.
MedicationStrong Evidence
Increase
Denosumab, a twice-yearly injection that blocks bone breakdown
Denosumab consistently raises lumbar spine bone density and reduces fracture risk, including in people with chronic kidney disease or on long-term steroids. In a network meta-analysis it produced some of the largest BMD gains of any agent studied.
MedicationStrong Evidence
Increase
Teriparatide or abaloparatide, daily injections that stimulate bone building
These are bone-forming drugs reserved for severe osteoporosis or fracture-prone patients. Both raise lumbar spine bone density more than placebo across multiple trials, with abaloparatide showing comparable or slightly greater spine gains than teriparatide in a head-to-head meta-analysis.
MedicationStrong Evidence
Decrease
Long-term systemic glucocorticoid use (such as prednisone)
Oral steroids accelerate bone loss, especially at the spine. In children, just 2 to 6 weeks of systemic steroids dropped lumbar spine bone density by about 1.7 percent at 6 weeks and 3.8 percent at 3 months. In children and adolescents with secondary osteoporosis, higher cumulative steroid dose tracked with lower Z-scores and more vertebral fractures.
MedicationStrong Evidence
Increase
Oral bisphosphonates such as alendronate or risedronate
Oral bisphosphonates are the most widely prescribed first-line drugs for low bone density. A meta-analysis of trials in older women with osteopenia found lumbar spine bone density rose by roughly 5.6 percent on treatment compared to placebo, with reductions in fracture risk.
MedicationModerate Evidence
Decrease
Selective serotonin reuptake inhibitors (SSRIs), a common antidepressant class
SSRIs are linked to lower spine bone density, particularly in older adults. A meta-analysis of 11 studies reported SSRI use was associated with lower lumbar spine bone density and a Z-score reduction of about 0.28 standard deviations. The drugs treat depression effectively, but bone health monitoring is reasonable on long-term use.
MedicationModerate Evidence
Decrease
Excess thyroid hormone replacement (over-replaced levothyroxine)
Taking more thyroid hormone than your body needs accelerates bone turnover and lowers spine bone density. In geriatric inpatients, levothyroxine use was associated with lower lumbar spine bone density after adjusting for confounders. The fix is not stopping treatment if hypothyroidism is real, but right-sizing the dose.
MedicationModerate Evidence
Decrease
Chronic proton pump inhibitor (PPI) use for reflux
Long-term PPI use is associated with lower spine bone density. In a NHANES analysis of men, chronic PPI use was linked to a lumbar spine T-score about 0.27 standard deviations lower than non-users, alongside degraded bone microarchitecture. A UK twin cohort found similar reductions in bone density.
MedicationModest Evidence
Increase
Metformin for type 2 diabetes
Beyond its glucose effects, metformin appears to protect bone. A Mendelian randomization study found genetically proxied metformin treatment was associated with higher lumbar spine, femoral neck, and heel bone density, along with lower osteoporosis and fracture risk. A meta-analysis of anti-diabetic drugs found metformin had the strongest bone-protective signal.
MedicationModest Evidence

Frequently Asked Questions

References

21 studies
  1. Hilkens L, Van Schijndel N, Weijer VCR, Boerboom M, Van Der Burg E, Peters V, Kempers R, Bons J, Van Loon LV, Van Dijk JMedicine and Science in Sports and Exercise2022
  2. Markarian a, Taaffe D, Bettariga F, Luo H, Galvão D, Wilkie J, Peddle-mcintyre C, Newton RUOsteoporosis International2025
  3. Jang M, Shin C, Kim S, Lee JW, Chung N, Cho B, Jung M, Suh BK, Ahn MAnnals of Pediatric Endocrinology & Metabolism2022
  4. Magallares B, Malouf J, Codes-méndez H, Park H, Betancourt J, Fraga G, Quesada-masachs E, López-corbeto M, Torrent M, Marín a, Herrera S, Gich I, Boronat S, Casademont J, Corominas H, Cerdá DFrontiers in Endocrinology2025
  5. Ma J, Siminoski K, Alos N, Halton J, Ho J, Lentle B, Matzinger M, Shenouda N, Atkinson S, Barr RJournal of Clinical Endocrinology and Metabolism2015